A top-down analysis of the decentralized trial model’s benefits and impact on the industry.
Sharon Duffy
Advertisement
Articles by Sharon Duffy
Advertisement
Latest Updated Articles
Navigating a Decentralized Trial Model and the Changing Clinical Landscape During COVID-19Published: February 24th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Honing the Power of AI for Next Generation Trial Oversight and Execution
3
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
4
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
